These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8178907)

  • 1. New progestins--clinical experiences: gestodene.
    Shoupe D
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1562-8. PubMed ID: 8178907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two triphasic oral contraceptives containing either gestodene or norethindrone: a randomized, controlled trial.
    Weber-Diehl F; Lehnert J; Lachnit U
    Contraception; 1993 Oct; 48(4):291-301. PubMed ID: 8222658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestodene-containing contraceptives.
    Kuhl H; Jung-Hoffmann C; Wiegratz I
    Clin Obstet Gynecol; 1995 Dec; 38(4):829-40. PubMed ID: 8616979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical aspects of three new progestogens: desogestrel, gestodene, and norgestimate.
    Chez RA
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1296-300. PubMed ID: 2524163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desogestrel, norgestimate, and gestodene: the newer progestins.
    Kaplan B
    Ann Pharmacother; 1995; 29(7-8):736-42. PubMed ID: 8520092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of the new progestogens in combination oral contraceptives.
    Rebar RW; Zeserson K
    Contraception; 1991 Jul; 44(1):1-10. PubMed ID: 1832625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New progestogens in oral contraceptives.
    Runnebaum B; Rabe T
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1059-63. PubMed ID: 2960242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
    Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
    Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 20 micrograms ethinylestradiol/150 micrograms desogestrel, with respect to efficacy, cycle control and tolerance.
    Endrikat J; Jaques MA; Mayerhofer M; Pelissier C; Müller U; Düsterberg B
    Contraception; 1995 Oct; 52(4):229-35. PubMed ID: 8605781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
    Bonnar J; Daly L; Carroll E
    Int J Fertil; 1987; 32 Suppl():21-8. PubMed ID: 2906344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative studies of 30 micrograms ethinyl estradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis, and platelets.
    Daly L; Bonnar J
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):430-7. PubMed ID: 2142580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic changes during treatment with two different progestogens.
    Refn H; Kjaer A; Lebech AM; Borggaard B; Schierup L; Bremmelgaard A
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):374-7. PubMed ID: 2115298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gestodene. A review of its pharmacology, efficacy and tolerability in combined contraceptive preparations.
    Wilde MI; Balfour JA
    Drugs; 1995 Aug; 50(2):364-95. PubMed ID: 8521763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and metabolic effects of a triphasic pill containing gestodene.
    Fruzzetti F; Ricci C; Nicoletti I; Fioretti P
    Contraception; 1992 Oct; 46(4):335-47. PubMed ID: 1486772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestodene: a review of its pharmacology, potency and tolerability in combined contraceptive preparations.
    Stanczyk FZ; Archer DF
    Contraception; 2014 Apr; 89(4):242-52. PubMed ID: 24485094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and metabolic effects of gestodene and levonorgestrel.
    Rabe T; Runnebaum B; Kohlmeier M; Harenberg J; Weicker H
    Int J Fertil; 1987; 32 Suppl():29-44. PubMed ID: 2906345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thirty years after the appearance of the first oral contraceptive, clinical and biological analysis of a new estrogen-progestin combination, a three phase pill containing gestodene].
    Belaisch J; Hommais-loufrani B
    Fertil Contracept Sex; 1988 Apr; 16(4 Suppl):1-8. PubMed ID: 12342078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A norgestimate-containing oral contraceptive: review of clinical studies.
    Kafrissen ME
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1196-202. PubMed ID: 1415446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.